More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Influenza A virus H1N1 NA (Neuraminidase) antibody

Influenza A virus H1N1 NA (Neuraminidase) antibody

GTX125974
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
ReactivityVirus
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    Influenza A virus H1N1 NA (Neuraminidase) antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.11 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Rabbit
  • Isotype
    IgG
  • Scientific Description
    Influenza A subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. There are 16 different HA antigens (H1-H16) and nine different NA antigens (N1-N9) for Influenza A. The extent of infection into host organisms is determined by HA, which interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues.
  • Reactivity
    Virus
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Mohamed IMA, Ogawa H, Takeda Y. In vitro virucidal activity of the theaflavin-concentrated tea extract TY-1 against influenza A virus. J Nat Med. 2022,76(1):152-160. doi: 10.1007/s11418-021-01568-0
    Read this paper
  • Liu X, Xu F, Ren L, et al. MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes. Nat Commun. 2021,12(1):4427. doi: 10.1038/s41467-021-24724-2
    Read this paper
  • Declercq M, Biquand E, Karim M, et al. Influenza A virus co-opts ERI1 exonuclease bound to histone mRNA to promote viral transcription. Nucleic Acids Res. 2020,48(18):10428-10440. doi: 10.1093/nar/gkaa771
    Read this paper
  • Takeda Y, Murata T, Jamsransuren D, et al. Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2. Viruses. 2020,12(7). doi: 10.3390/v12070699
    Read this paper
  • Esparza M, Mor A, Niederstrasser H, et al. Chemical intervention of influenza virus mRNA nuclear export. PLoS Pathog. 2020,16(4):e1008407. doi: 10.1371/journal.ppat.1008407
    Read this paper
  • Choi JG, Kim YS, Kim JH, et al. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition. Sci Rep. 2019,9(1):12132. doi: 10.1038/s41598-019-48430-8
    Read this paper
  • Zhang K, Xie Y, Muñoz-Moreno R, et al. Structural basis for influenza virus NS1 protein block of mRNA nuclear export. Nat Microbiol. 2019,4(10):1671-1679. doi: 10.1038/s41564-019-0482-x
    Read this paper
  • Lin HT, Chen CC, Liu PY, et al. Grail attenuates influenza A virus infection and pathogenesis by inhibiting viral nucleoprotein. Sci Rep. 2018,8(1):17242. doi: 10.1038/s41598-018-35722-8
    Read this paper
  • Kuss-Duerkop SK, Wang J, Mena I, et al. Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication. PLoS Pathog. 2017,13(9):e1006635. doi: 10.1371/journal.ppat.1006635
    Read this paper

Datasheet

Download Datasheet

FAQ

Go to our frequently asked questions